At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare. An estimated five million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 120 years of experience and 18,500 patents globally. With about 65,000 dedicated colleagues in over 70 countries, we will continue to innovate and shape the future of healthcare.
Purpose-led, performance-driven Royal DSM is a global, purpose-led leader in health and nutrition, applying bioscience to improve the health of people, animals, and the planet. DSM’s purpose is to create brighter lives for all which we achieve through developing products and solutions that address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value.
Organogenesis is the established skin substitutes market leader – and have been since Q2 ‘2020. Organogenesis is focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care, and surgical and sports medicine markets.
At IGM Biosciences, we believe that real innovation comes from looking beyond current approaches to envision a better way to address disease. Given the limitations of the widely used IgG antibody, we asked how we could use IgM antibodies, a naturally occurring, but different, class of antibody to help patients. We believed that an IgM could be a better antibody medicine that could be more effective at treating certain diseases.
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. Founded in 2017, our headquarters is located in San Diego, California, with additional operations located in the San Francisco Bay area.
Founded in 1999, BGI is one of the world's leading life science and genomics organizations. BGI’s mission is to use genomics to benefit mankind and to be a leader in the era of life sciences. BGI follows a genomics development model of “research, production and application”. With businesses in more than 100 countries and regions around the world, BGI has established cooperation and partnerships with thousands of different organizations across multi-disciplinary research areas including medical health, resource conservation and judicial services. At the same time, BGI provides equipment, technical support and solutions for the needs of national economies and people's livelihoods, such as precision medicine and precision health. BGI is committed to applying its genetic and technological achievements to real world settings in order to realize the dream of trans-omics for a better life.